blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2792347

EP2792347 - Pharmaceutical compositions for the treatment of inner ear disorders [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  12.04.2019
Database last updated on 24.08.2024
FormerExamination is in progress
Status updated on  01.11.2016
Most recent event   Tooltip12.04.2019Application deemed to be withdrawnpublished on 15.05.2019  [2019/20]
Applicant(s)For all designated states
Auris Medical AG
Falknerstrasse 4
4001 Basel / CH
[2014/43]
Inventor(s)01 / Meyer, Thomas
Birkenweg 6
4528 Zuchwil / CH
 [2014/43]
Representative(s)Graf von Stosch, Andreas, et al
Graf von Stosch
Patentanwaltsgesellschaft mbH
Prinzregentenstraße 22
80538 München / DE
[N/P]
Former [2014/43]Graf von Stosch, Andreas, et al
Graf von Stosch Patentanwaltsgesellschaft mbH Prinzregentenstrasse 22
80538 München / DE
Application number, filing date14001796.328.09.2005
[2014/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2792347
Date:22.10.2014
Language:EN
[2014/43]
Search report(s)(Supplementary) European search report - dispatched on:EP24.09.2014
ClassificationIPC:A61K9/00, A61K31/137, A61P27/16
[2014/43]
CPC:
A61K9/0046 (EP,NO,US); A61K31/137 (EP,KR,US); A61K9/10 (NO,US);
A61F11/00 (US); A61K31/136 (EP,US); A61K31/4535 (EP,US);
A61K31/47 (EP,US); A61K31/573 (EP,US); A61K31/728 (KR);
A61K45/06 (US); A61K47/10 (US); A61K47/34 (US);
A61M31/00 (US); A61P27/00 (EP); A61P27/16 (EP);
A61P37/06 (EP); A61P43/00 (EP); A61K31/135 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2014/43]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:Pharmazeutische Zusammensetzungen zur Behandlung von Erkrankungen des Innenohrs[2014/43]
English:Pharmaceutical compositions for the treatment of inner ear disorders[2014/43]
French:Compositions pharmaceutiques pour le traitement de troubles de l'oreille interne[2014/43]
Examination procedure22.05.2014Examination requested  [2014/43]
03.07.2015Amendment by applicant (claims and/or description)
20.10.2016Despatch of a communication from the examining division (Time limit: M06)
28.04.2017Reply to a communication from the examining division
25.07.2017Despatch of a communication from the examining division (Time limit: M04)
03.11.2017Reply to a communication from the examining division
24.07.2018Despatch of a communication from the examining division (Time limit: M04)
04.12.2018Application deemed to be withdrawn, date of legal effect  [2019/20]
09.01.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2019/20]
Parent application(s)   TooltipEP05797324.0  / EP1928405
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
03.07.2015Request for further processing filed
03.07.2015Full payment received (date of receipt of payment)
Request granted
17.07.2015Decision despatched
Fees paidRenewal fee
22.05.2014Renewal fee patent year 03
22.05.2014Renewal fee patent year 04
22.05.2014Renewal fee patent year 05
22.05.2014Renewal fee patent year 06
22.05.2014Renewal fee patent year 07
22.05.2014Renewal fee patent year 08
22.05.2014Renewal fee patent year 09
28.07.2014Renewal fee patent year 10
06.07.2015Renewal fee patent year 11
18.07.2016Renewal fee patent year 12
12.09.2017Renewal fee patent year 13
11.09.2018Renewal fee patent year 14
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]WO9810757  (US HEALTH [US]) [I] 1-15 * page 4, lines 4-12 * * page 8, lines 8-10 * * claims 1,19,20 *;
 [AD]WO2004022069  (DURECT CORP [US], et al) [AD] 1-15 * example 4 * * claims 1,5 *;
 [I]WO2004043902  (GRUENENTHAL GMBH [DE], et al) [I] 1-15 * claims 1,9-12 *;
 [E]WO2005094799  (AURIS MEDICAL AG [CH], et al) [E] 1-15 * claims 1-3 ** paragraphs [0031] , [0036] *;
 [I]  - TABUCHI KEIJI ET AL, "Effect of Ketamine, Dextromethorphan, and MK-801 on Cochlear Dysfunction Induced by Transient Ischemia", ANNALS OF OTOLOGY, RHINOLOGY AND LARYNGOLOGY, ANNALS PUBL., ST. LOUIS, MO, US, (20020101), vol. 111, no. 1, ISSN 0003-4894, pages 44 - 49, XP009162587 [I] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1177/000348940211100107
 [A]  - GUITTON M J ET AL, "NEW PHARMACOLOGICAL STRATEGIES TO RESTORE HEARING AND TREAT TINNITUS", ACTA OTO-LARYNGOLOGICA, SCANDINAVIAN UNIVERSITY PRESS, OSLO, NO, (20040501), vol. 124, no. 4, doi:10.1080/00016480310000665, ISSN 0001-6489, pages 411 - 415, XP008054645 [A] 1-15 * abstract * * figure 4 *

DOI:   http://dx.doi.org/10.1080/00016480310000665
by applicantUS3254124
 DE2062620
 WO9408599
 US5421818
 US5474529
 US5476446
 WO9738698
 US6045528
 US6120484
 US6309410
 WO0198265
 US6377849
 US2002082554
 WO2004022069
 WO2004064912
    - VESTERARGER V., BRITISH MEDICAL JOURNAL, (1997), vol. 314, no. 7082, pages 728 - 731
    - SAHLEY T.; NODAR R., HEARING RESEARCH, pages 43 - 54
    - CHEN ET AL., AUDIOL. NEUROOTOL., (2003), vol. 8, pages 49 - 56
    - LIGHT J.; SILVERSTEIN H., CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, (2004), pages 378 - 383
    - GOYCOOLEA M.; LUNDMAN L., MICROSCOPY RESEARCH AND TECHNIQUE, (1997), vol. 36, pages 201 - 211
    - SELIVANOVA ET AL., LARYNGO-RHINO-OTOL, (2003), pages 235 - 239
    - CHANDRASEKHAR S., OTOLOGY & NEUROTOLOGY, (2001), pages 18 - 23
    - HOFFER ET AL., OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, (2004), pages 1053 - 1060
    - SAKATA ET AL., INTERNATIONAL TINNITUS JOURNAL, (1996), pages 129 - 135
    - HOFFER ET AL., OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, (2003), pages 353 - 358
    - VOLLENWEIDER ET AL., EUR. NEUROPSYCHOPHARMACOL., (1997), vol. 7, pages 25 - 38
    - Remington's Pharmaceutical Sciences, MACK PUBLISHING CO., (1990), vol. 18
    - LIGHT J.; SILVERSTEIN H., CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, (2004), vol. 12, pages 378 - 383
 US19950473008
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.